EUVIMEDEUVIMED entdecken
Crossref

Liver transplantation in patients with metabolic dysfunction and alcohol-related liver disease (MetALD)

Carlos E. Coronel-Castillo, Ximena Parraga, Leandro Sierra, Marco Arrese, Juan Pablo Arab, Luis Antonio Diaz

Metabolism and Target Organ Damage · 04.08.2026 · 6 (3)

DOI: 10.20517/mtod.2026.78 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 04.08.2026. Verfasst von Carlos E. Coronel-Castillo und 5 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction and alcohol-related liver disease (MetALD) represents an increasingly recognized and clinically relevant phenotype within the steatotic liver disease (SLD) spectrum, although underreporting of alcohol intake leads to misclassification and underestimation of its true prevalence. In the liver transplantation (LT) setting, MetALD has become the third leading etiology among individuals waitlisted and undergoing transplant in the United States. This review examines the clinical implications of MetALD from candidate evaluation through post-liver transplantation (post-LT) follow-up. In the pre-liver transplantation (pre-LT), candidates with MetALD exhibit a narrower window for clinical recovery after decompensation. This translates into a higher adjusted risk of delisting due to death or clinical deterioration compared with other etiologies of SLD. After transplantation, MetALD is associated with worse outcomes than ALD alone, including higher all-cause mortality and graft failure, reflecting the synergistic hepatic injury driven by combined metabolic and alcohol-related mechanisms. Beyond liver-related events, the metabolic substrate of MetALD poses a high cardiovascular risk, highlighting the importance of integrated pre-LT and post-LT management that combines rigorous cardiometabolic assessment, objective alcohol-use monitoring, and targeted surveillance strategies specific to this population.

Zitieren

APA

Coronel-Castillo, C. E., Parraga, X., Sierra, L., Arrese, M., Arab, J. P., & Diaz, L. A. (2026). Liver transplantation in patients with metabolic dysfunction and alcohol-related liver disease (MetALD). Metabolism and Target Organ Damage, 6(3). https://doi.org/10.20517/mtod.2026.78

Vancouver

Coronel-Castillo CE, Parraga X, Sierra L, Arrese M, Arab JP, Diaz LA. Liver transplantation in patients with metabolic dysfunction and alcohol-related liver disease (MetALD). Metabolism and Target Organ Damage. 2026;6(3). doi:10.20517/mtod.2026.78

BibTeX
@article{CoronelCastillo2026,
  author = {Coronel-Castillo, Carlos E. and Parraga, Ximena and Sierra, Leandro and Arrese, Marco and Arab, Juan Pablo and Diaz, Luis Antonio},
  title = {Liver transplantation in patients with metabolic dysfunction and alcohol-related liver disease (MetALD)},
  journal = {Metabolism and Target Organ Damage},
  year = {2026},
  volume = {6},
  number = {3},
  doi = {10.20517/mtod.2026.78}
}
Kostenlos starten →